PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITOR
The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English Spanish |
| Published |
07.07.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to processes for making the pharmaceutical compositions.
La presente invención hace referencia a con composiciones farmacéuticas del inhibidor c-Met, Compuesto 1. La invención también hace referencia a métodos de tratamiento de una enfermedad, un trastorno o un síndrome mediado al menos parcialmente por la modulación de la actividad in vivo de una proteína cinasa con la composición farmacéutica y a procesos para producir las composiciones farmacéuticas. |
|---|---|
| AbstractList | The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to processes for making the pharmaceutical compositions.
La presente invención hace referencia a con composiciones farmacéuticas del inhibidor c-Met, Compuesto 1. La invención también hace referencia a métodos de tratamiento de una enfermedad, un trastorno o un síndrome mediado al menos parcialmente por la modulación de la actividad in vivo de una proteína cinasa con la composición farmacéutica y a procesos para producir las composiciones farmacéuticas. |
| Author | CHEN, Tzu-Yuan LIEJANTO, Iswadi |
| Author_xml | – fullname: LIEJANTO, Iswadi – fullname: CHEN, Tzu-Yuan |
| BookMark | eNrjYmDJy89L5WQwDPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PcLVvB3U3BU8Pb0cwx2VfD08_B08gzxD-JhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOQUYGRsYGRkbGjsZEKAEABcAn2w |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | COMPOSICIONES FARMACÉUTICAS DE UN INHIBIDOR DE CINASA |
| ExternalDocumentID | CR20230223A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CR20230223A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:58:11 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Spanish |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CR20230223A3 |
| Notes | Application Number: CR20230000223 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230707&DB=EPODOC&CC=CR&NR=20230223A |
| ParticipantIDs | epo_espacenet_CR20230223A |
| PublicationCentury | 2000 |
| PublicationDate | 20230707 |
| PublicationDateYYYYMMDD | 2023-07-07 |
| PublicationDate_xml | – month: 07 year: 2023 text: 20230707 day: 07 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | EXELIXIS, INC |
| RelatedCompanies_xml | – name: EXELIXIS, INC |
| Score | 3.3228352 |
| Snippet | The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITOR |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230707&DB=EPODOC&locale=&CC=CR&NR=20230223A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH-Z06g3nRrnV3ow3IgQENyBGCgQMIESxsxuiy0s2UUXwfjv-1rZ9KK3pk1ev_L6-mvf7z2AW8t4cbm1xB1YchcByoOjc1Fbei1zdRscTfJEspGz3Elm9tP8fj6A1YYLo-KEfqrgiKhRAvW9U-f1-ucRK1S-le0dX2HV22NceaHWo2Pp1Wy4Whh4UcFCRjVKPVpqefndhqbQ34FdeYuWYfaj50CSUta_LUp8BHsFCnvtjmHQtCM4oJvEayPYz_r_biz2qteegFkkfpn5NJpVMoQBoSwr2DRVLGDCYuITBOL-NCJpnqRBWrHyFEgcVTTRse_Fdp4LWm5HaZ3BEOF_cw4E7xfCtGph2g2CMYlwbDHhwnawBk8yewzjP8Vc_NN2CYeyrFxP3SsYdu8fzTUa2I7fqKX5AqjYeWw |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rRrrcw-GGxECBXsgBhYIaHmEUtMbcYEmvWgjGP--syutXvS2mU1mX5mZ_XbnAXCrKS8m05Z4AktmIkC5N2RWVppc8VrdCkOTPOHRyFFsBHP9cTFe9GC1iYUReUI_RXJElKgS5b0V-nr984jlCt_K5o6tkPT24OeWK3XomHs1K6bkOpaXJm5CJUotmklx9t2HptDegV2TJ-flN6dnhwelrH9bFP8Q9lJk9toeQa9uhjCgm8JrQ9iPuv9ubHai1xyDmgZ2FtnUm-c8hQGhSZQms1BEAZPEJzZBIG7PPBLGQeiEeZKdAPG9nAYyjl1s11nQbDtL7RT6CP_rMyB4vyhVrSpVvUYwxhGOXk5YqRtIQU2mj2D0J5vzf_puYBDk0bSYhvHTBRxwunBDNS-h375_1FdobFt2LbbpC35sfFk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITIONS+OF+A+KINASE+INHIBITOR&rft.inventor=LIEJANTO%2C+Iswadi&rft.inventor=CHEN%2C+Tzu-Yuan&rft.date=2023-07-07&rft.externalDBID=A&rft.externalDocID=CR20230223A |